Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Infant Immunizations”

163 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 163 results

Large-scale testing (Phase 3)Study completedNCT01839175
What this trial is testing

Concomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in Healthy Infants During Primary Series Immunisation Followed by Booster Vaccination

Who this might be right for
Neisseria MeningitidisBacterial InfectionsVirus Diseases
Sanofi Pasteur, a Sanofi Company 350
Not applicableStudy completedNCT03918096
What this trial is testing

Evaluation of Immunization Coverage of Premature Infants Leaving CHU d'Angers According to the Recommended Regimen During the First 4 Months (VACCIPREM)

Who this might be right for
Premature Birth
University Hospital, Angers 384
Post-approval studies (Phase 4)Study completedNCT00168662
What this trial is testing

Non-Specific Effects of Standard Titre Measles Vaccination

Who this might be right for
Measles
Bandim Health Project 7,800
Post-approval studies (Phase 4)Study completedNCT03125616
What this trial is testing

Babies Born Early Antibody Response to Men B Vaccination: BEAR Men B

Who this might be right for
PrematurityVaccinationMeningococcal Disease
St George's, University of London 136
Large-scale testing (Phase 3)Active Not RecruitingNCT06975878
What this trial is testing

Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age

Who this might be right for
Pneumococcal ImmunizationHealthy Volunteers
Sanofi 1,092
Testing effectiveness (Phase 2)Study completedNCT02726178
What this trial is testing

Cardio-respiratory Events and Inflammatory Response After Primary Immunization in Preterm Infants

Who this might be right for
Complication Due to Immunization
St. Justine's Hospital 56
Not applicableStudy completedNCT03614676
What this trial is testing

Outcomes and Events of Interest in Pregnant Women, Neonates and Infants and of RSV Surveillance

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 4,493
Post-approval studies (Phase 4)Study completedNCT03587389
What this trial is testing

Response to Rotavirus Vaccine in Infants in Ho Chi Minh City in Vietnam

Who this might be right for
RotavirusDiarrhea
Oxford University Clinical Research Unit, Vietnam 818
Not applicableStudy completedNCT00150189
What this trial is testing

Utilization of Oral Sucrose to Decrease Pain in Infants During Immunizations

Who this might be right for
PainProcedural Pain
Milton S. Hershey Medical Center 140
Testing effectiveness (Phase 2)Study completedNCT02347423
What this trial is testing

3 Adjuvated Reduced Dose IPV-Al SSI and Non-adjuvated Full Dose IPV SSI Given as Primary Vaccinations to Infants

Who this might be right for
Poliomyelitis
Statens Serum Institut 824
Testing effectiveness (Phase 2)Active Not RecruitingNCT06647407
What this trial is testing

Safety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine Against Meningococcal Disease in Children, Toddlers, and Infants

Who this might be right for
Meningococcal ImmunizationHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 750
Large-scale testing (Phase 3)Study completedNCT01339923
What this trial is testing

A Phase 3B, Open Label, Multi-Center Study to Evaluate the Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine When Administered Alone to Healthy Infants According to Different Immunization Schedules and to Healthy Children Aged 2 to 10 Years

Who this might be right for
Meningococcal DiseaseMeningococcal Meningitis
Novartis Vaccines 1,409
Large-scale testing (Phase 3)Study completedNCT05437510
What this trial is testing

Study of a Single Intramuscular Dose of Nirsevimab in the Prevention of Hospitalizations Due to Respiratory Syncytial Virus (RSV) Infection in Healthy Term and Preterm Infants During the First Year of Life

Who this might be right for
RSV ImmunizationHealthy Volunteer
Sanofi Pasteur, a Sanofi Company 8,057
Not applicableStudy completedNCT05389020
What this trial is testing

Immunisation Simulation Using the Real-size Infant Manikin in Medical Education

Who this might be right for
Immunization Skills
Universitas Indonesia 205
Not applicableStudy completedNCT01496079
What this trial is testing

Maternal Immunization: Giving Immunity For Tomorrow

Who this might be right for
PregnancyInfluenza
University of Utah 166
Testing effectiveness (Phase 2)Study completedNCT00721396
What this trial is testing

Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered With or Without Routine Infant Vaccinations to Healthy Infants According to Different Immunization Schedules

Who this might be right for
Meningococcal Infections
Novartis Vaccines 1,885
Large-scale testing (Phase 3)Looking for participantsNCT07232706
What this trial is testing

Prevention of RSV Infection in Infants by Administering Nirsevimab to Infants, With or Without Maternal RSV Vaccination

Who this might be right for
RSV Immunization
Centre Hospitalier Annecy Genevois 1,000
Post-approval studies (Phase 4)Study completedNCT03489018
What this trial is testing

The Effect of Fractional Doses of Pneumococcal Conjugate Vaccines on Immunogenicity and Carriage in Kenyan Infants

Who this might be right for
Pneumococcal InfectionStreptococcus Pneumoniae InfectionInvasive Pneumococcal Disease, Protection Against
London School of Hygiene and Tropical Medicine 2,100
Large-scale testing (Phase 3)Study completedNCT03188692
What this trial is testing

Safety and Efficacy of BK1310 Intramuscular Injection in Healthy Infants

Who this might be right for
Immunization
Tanabe Pharma Corporation 33
Testing effectiveness (Phase 2)Active Not RecruitingNCT06790290
What this trial is testing

Phase 2 Trial to Evaluate Safety and Immunogenicity of Inventprise's (IVT) 25-valent Pneumococcal Conjugate Vaccine (IVT PCV-25) in Healthy Infants

Who this might be right for
Pneumococcal Disease, Invasive
Inventprise Inc. 421
Next Page